Schroders Capital

About Schroders Capital

Schroders Capital is the private markets arm of Schroders plc with £70.1 billion of assets under management as of December 2024 (approximately $88 billion / €85 billion), headquartered in London. The firm operates as a wholly-owned subsidiary of Schroders plc, which is listed on the London Stock Exchange and is a FTSE 100 constituent with parent founding date 1804. Schroders Capital was rebranded in 2021, consolidating the parent group's private markets activity across 25 offices globally. The platform anchors into Schroders Group's broader $1 trillion distribution infrastructure.

Investment thesis

Schroders Capital deploys capital across multiple flagship vehicles spanning private equity (direct plus GP-led continuation secondaries), private debt and credit alternatives, real estate, infrastructure and multi-private-markets solutions, with 400 plus active GP relationships. Sector focus spans healthcare and life sciences, technology, energy transition, real estate, infrastructure (renewables) and microfinance via the BlueOrchard subsidiary. Geographic deployment is global across UK, Continental Europe, US and Asia-Pacific, supported by 25 offices and integration into the Schroders parent platform. Recent flagship products include Crown semi-liquid vehicles, Schroders Capital Global Innovation Trust and Schroders Capital Semi-Liquid Global Private Equity.

Recent activity

Recent realised exits include biotech and life sciences (2025) and public equity holdings in life sciences and sequencing technology (2024). Recent acquisitions include the Future Growth Capital joint venture with Phoenix Group (2024) and continued build-out of semi-liquid private markets vehicles (2024-2025). The platform continues active fundraising across multi-strategy private markets programmes anchored by the Schroders Group $1 trillion distribution platform. Detailed buyer names and multiple data available on Pro at €29/month.